chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness; Vertigo; Bruising at injection site; Some slight nausea the evening of and morning after receiving the vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8732) via an unspecified route of administration in the left arm on 26Mar2021 at 09:30 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Medical history included known allergies to sulfa drugs. The concomitant medications included escitalopram (MANUFACTURER UNKNOWN), ascorbic acid; pyridoxine hydrochloride; biotin; folic acid; cholecalciferol; cyanocobalamin; choline bitartrate; inositol; calcium pantothenate; retinol palmitate; zinc citrate; potassium iodide; Dl-alpha tocopherol acetate (SUGAR BEAR HAIR VITAMIN) for unknown indications from unknown dates. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent PCR test (nasal swab) on 27Feb2021 and the result was negative. On 26Mar2021, the patient experienced some slight nausea at the evening and morning after receiving the vaccine. On 27Mar2021 (the day following the vaccine), the patient experienced dizziness and vertigo. The patient also experienced small bruising at the injection site. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had tested for COVID-19 that included PCR test on an unknown date in Mar2021 and the result was unknown. The clinical outcome of the events nausea, dizziness, vertigo and vaccination site bruising was resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a registered nurse refers to multiple unspecified patients of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On unspecified dates, the patients were vaccinated with improperly stored ROTATEQ lot/batch # L035511, expiry date 21-MAY-2017 (dose, strength, vaccination site and route unspecified). The temperature excursion was reported as 34F for 48 hours. No adverse effect were reported. Product quality complain (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to a 5 year old patient. On 22-MAY-2009 the patient was vaccinated with the first dose of M-M-R II (strength, dose and frequency were not provided). On 29-MAY-2013 the patient was vaccinated with an expired 2nd dose of M-M-R II (batch # 664546, lot #664546/0906Z, expiration date 09-JUL-2012) (strength, dose and frequency were not provided). No adverse effects reported. Additional information has been requested.
Patient complained of chills, nausea and dizziness.  Temperature obtained was 102.0.  No other symptoms.
12 days fever 100F or above; stomach ache; diarrhea; headache; insomnia; rash near injection site; itchy '"all over"; fussiness; temper tantrums; lethargy
1 hr. after immunizations given he started a fever and has every day since then, with a high fever of 102.7. Is vomiting and having a decreased number of wet diapers. Runny nose a little. Dx: Fever, neutropenia, vomiting, dehydration.
Had tinnitus prior to first moderna vaccine, aprroximately 7 days after vaccine noticed tinnitus has worsened.
One hour 10 minutes after dose employee was at work station, stood up, felt faint and fell to the ground. Regained consciousness in less than 30 seconds and asked for help from nearby co worker. She was taken by ambulance to Hospital due to recent hip injury and fall to insure no further injury occurred.  Pt has previously passed out while receiving flu vaccine.  Pt is currently using a knee scooter to assist with mobility.
Patient received Fluarix vaccine at 5:10 PM. She stayed seated in vaccination area for 15 minutes and did not experience any initial adverse effects. Patient left the store and came back within 1-2 minutes and stated that she was experiencing numbness of her entire left arm in which vaccine was administered. She also was experiencing tightness in her throat, facial flushing, dizziness, shortness of breath, and involuntary tears from both eyes. I, the intern who adminstered the vaccine, immediately knew she was having an anaphylactic reaction. I immediately notified the pharmacist in charge and the pharmacy technician called 911. Epipen (adult dose) was administered to the patient within a minute of identifying anaphylactic reaction. Paramedics arrived shortly after and administered IV Benadryl 25 mg and took patient to the ER.
Vaccines administered about 11:30 am-apx 10-15 min after shot pt became pale, diaphoretic, nauseated and light headed. No LOC. No V. Pt returned to room-lay down 12N alert and approp but sleepy. P84, BP 80/40, R12, PO98 PERRLA. 12:20pm BP80/40. 12:50p pt happy, alert, talkative BP88/48, P88, PERRLA, 1pm pt d/c to home.
Injection Site Pain; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Injection Site Pain) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced INJECTION SITE PAIN (Injection Site Pain). On 13-Feb-2021, INJECTION SITE PAIN (Injection Site Pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Shortness of breath, burning sensation throughout the body. Itchy throat, tightness of throat. Received Epipen, then went to ED.
injection spot is red; injection spot is itching; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), INJECTION SITE ERYTHEMA (injection spot is red) and INJECTION SITE PRURITUS (injection spot is itching) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). On 10-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (injection spot is red) and INJECTION SITE PRURITUS (injection spot is itching). On 03-Feb-2021, PAIN IN EXTREMITY (arm was sore) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (injection spot is red) and INJECTION SITE PRURITUS (injection spot is itching) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Rash and fever developed 1 week after MMR seen in ER and diagnosed with measle-like flat rash mostly at the trunk and back. Lasted 2 days.
Information has been received from a neurologist via a company representative concerning a currently 16 years old female patient. The patient's concomitant therapy, concurrent condition, historical condition and drug reaction were not provided. The patient received three doses of GARDASIL (strength, dose, frequency, route, lot# and expiration date were unknown) on 02-JUL-2013, 06-SEP-2013 and 09-JAN-2014 respectively for prevention of human papillomavirus by an anonymous physician. In May 2016, the patient developed lethargy and had three episodes of dizziness. The patient was evaluated by a neurologist in July 2016. On an unknown date, the patient was diagnosed with postural orthostatic tachycardia syndrome (POTS). The outcome of the event was reported as not recovered. The causality between the event and GARDASIL was unknown. Additional information has been requested.
9 days later, she had some upper Respiratory congestion that was mild; chills; mild headache; Patient felt weak most of the day 8 days after receiving 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Patient felt weak most of the day 8 days after receiving 2nd dose), UPPER RESPIRATORY TRACT CONGESTION (9 days later, she had some upper Respiratory congestion that was mild), CHILLS (chills) and HEADACHE (mild headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 19-Mar-2021, the patient experienced ASTHENIA (Patient felt weak most of the day 8 days after receiving 2nd dose). On 20-Mar-2021, the patient experienced UPPER RESPIRATORY TRACT CONGESTION (9 days later, she had some upper Respiratory congestion that was mild), CHILLS (chills) and HEADACHE (mild headache). At the time of the report, ASTHENIA (Patient felt weak most of the day 8 days after receiving 2nd dose), UPPER RESPIRATORY TRACT CONGESTION (9 days later, she had some upper Respiratory congestion that was mild), CHILLS (chills) and HEADACHE (mild headache) outcome was unknown. Not Provided          The patient did not receive any treatment medications.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Reporter details updated
On 12/31/2020 patient noticed a "Golf ball sized" knot behind collarbone on left side (side vaccinated). She did go see her PCP because she didn't know what the knot was. She was told that it was possibly a swollen lymph node. She does have a follow-up appointment with PCP for further evaluation. She reports that it is getting better with each day. No treatment rendered by PCP.
This is a spontaneous report from a contactable consumer (Patient, reported for self). A 38-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: Wag 10838, Expiration Date: not reported) via an unspecified route of administration in left arm on 02Jun2021 as dose 1, single for COVID-19 immunization. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's medical history and concomitant medications were not reported. Patient reported that "between vaccine 1 & 2, patient started feeling pain in my right ankle, which turned into severe pain" on 27Jun2021. The adverse event resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The patient received treatment with steroids for the adverse event. The event was reported as non-seriousness. The outcome of the event was reported as recovering. Device Date : 04Jul2021
Hurt like hell; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingrix (1st dose received on unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 28-AUG-2022 Reporter's comment: This case was reported by the patient via interactive digital media. The patient just got his/her final shingles shot. The patient had experienced hurt like hell but was glad he/she had done. Additional supportive information: The follow-up would not possible, as no contact details were available.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients. Beginning on 08-FEB-2018, the patients were vaccinated with improperly stored GARDASIL 9 lot # N021572, expiry: 01-MAY-2020; N020352, expiry: 10-APR-2020; N009173, expiry: 20-NOV-2019; N014470, expiry: 17-JUN-2019, PEDVAXHIB lot # N014944, expiry: 06-MAR-2020; M046134, expiry: 27-SEP-2019; M014927, expiry 18-FEB-2019, PNEUMOVAX 23 lot # N020688, expiry: 09-MAR-2019; N014946, expiry: 01-FEB-2019; N010106, expiry: 15-NOV-2018, VAQTA lot # N016805, expiry: 04-SEP-2018; N020503, expiry: 04-SEP-2018, ROTATEQ lot # reported as N004810, expiry: 21-OCT-2018; lot number reported as M040606, 28-JUN-2018; M042170, expiry: 22-JUN-2018. The vaccines underwent a temperature excursion of 32 to 35 degrees Fahrenheit for 2 minutes. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. Lot numbers N004810 and M040606 are invalid lot numbers for rotavirus vaccine, live, oral, pentavalent.
Low grade nausea, fatigue, slight headache, all developing around 7 hours after injection and increasing in intensity until about 28 hours after injection. Lightheadedness while standing up 21 hours after injection, unable to remain standing, then slept HARD for 5 hours. Some joint pain in shoulder/elbow/wrist of left arm from about 8 hours after injection, gone upon waking in the morning. Resting heart rate from 66bpm to 75bpm (per Fitbit) on the day after injection, and dropping to 73bpm today Dec 11
FLUAD reaction: Per patient in right arm, started with pain in shoulder more severe on Tuesday. On Wednesday (today)  he experienced elbow pain but shoulder pain was gone. He couldn't left a coffee cup without pain. Pain was worse on Wednesday. He could raise his arm.
I am having tachycardia; Feel anxious; I have unexplained heart problems; I always feel like my body's sympathetic nervous system has gone on over drive; Body pain, aches; Not able to do much; That night I got sick; With a temperature of 103 degrees Fahrenheit; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (That night I got sick), TACHYCARDIA (I am having tachycardia), ANXIETY (Feel anxious), CARDIAC DISORDER (I have unexplained heart problems) and NERVOUS SYSTEM DISORDER (I always feel like my body's sympathetic nervous system has gone on over drive) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cardiac disorder NOS.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced ILLNESS (That night I got sick), PYREXIA (With a temperature of 103 degrees Fahrenheit) and CHILLS (Chills). On 28-Apr-2021, the patient experienced MYALGIA (Body pain, aches) and FATIGUE (Not able to do much). On 02-Jul-2021, the patient experienced TACHYCARDIA (I am having tachycardia), ANXIETY (Feel anxious), CARDIAC DISORDER (I have unexplained heart problems) and NERVOUS SYSTEM DISORDER (I always feel like my body's sympathetic nervous system has gone on over drive). On 05-May-2021, ILLNESS (That night I got sick), MYALGIA (Body pain, aches), PYREXIA (With a temperature of 103 degrees Fahrenheit), CHILLS (Chills) and FATIGUE (Not able to do much) had resolved. At the time of the report, TACHYCARDIA (I am having tachycardia), ANXIETY (Feel anxious), CARDIAC DISORDER (I have unexplained heart problems) and NERVOUS SYSTEM DISORDER (I always feel like my body's sympathetic nervous system has gone on over drive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Apr-2021, Body temperature: 103 (High) 103 degrees Fahrenheit.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included  Beta Blockers, Anxiety Medications and Cholesterol Medications.  Treatment information was not provided.   This case was linked to MOD-2021-245625 (Patient Link).
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 06-FEB-2019, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R019391 with expiration date 05-JUL-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010341: US-009507513-1907USA010342: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010372: US-009507513-1907USA010373:
Actual cause of death unknown. Pending Coroner Report. The autopsy report states SIDS.
Exhaustion, fatigue, low grade fever, diffuse red blotchy rash over stomach, chest, back, shoulders, armpits. Took naproxen, Tylenol and Benadryl. Rash is still ongoing. Other symptoms have resolved.
Pt received Dose 1 as Moderna 8/12/2022, dose 2 was given as Pfizer by accident
This spontaneous report as received from a registered nurse (R.N.) refers to an unknown number of patients of  unknown age and gender. No relevant medical history or concurrent conditions were reported. On unknown dates (before expiration date), the patients were vaccinated with improperly stored PNEUMOBAX23 (lot # K008410, expiration date 26-FEB-2016; dose and route were not reported). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt noticed pruritic rash on neck on 02/27/03. Presented to MD and diagnosed with generalized vaccinia on 03/03/03.
Higher sugar levels in blood; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of BLOOD GLUCOSE INCREASED (Higher sugar levels in blood) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic and Cholesterol. Concomitant products included ATORVASTATIN for Cholesterol, METFORMIN and GLIMEPIRIDE for Diabetes, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced BLOOD GLUCOSE INCREASED (Higher sugar levels in blood). At the time of the report, BLOOD GLUCOSE INCREASED (Higher sugar levels in blood) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Epididymitis; Severe testicle pain; This is a spontaneous report from a contactable consumer (patient). A 28-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), second dose, via an unspecified route of administration, in the left arm on 27Mar2021 at 09:30 am (Batch/Lot Number: ER8727) as a single dose for COVID-19 immunization at a clinic. Medical history was reported as none. There were no known allergies. The patient previously received the first dose of the BNT162B2  (Batch/Lot Number: EN6202) on 06Mar2021 at 10:00 am in the left arm. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included omeprazole and cetirizine.  On 24Apr2021 at 02:00 am, the patient reported hospitalized in the ER with severe testicle pain. Ultrasound revealed epididymitis which he never had before and his wife and him have only ever been with each other. The result of the urine sample was not reported. The adverse event resulted in emergency room/department or urgent care visit. Treatment was reported as ultrasound and urine sample. The events were reported as nonserious. Since the vaccination, the patient has not been tested for COVID-19. The patient did not test positive for COVID-19 post vaccination. The outcome of events epididymitis and testicle pain was recovering.
very itchy rash on abd;no h/a, no nausea, no fever, no diarrhea or reduction of stool no other sx;hydrocortisone cream helped w/itching;
Post vax, the patient did not serconvert. The nurse reported that they wanted to give the patient a booster shot, but the patient was on valacyclovir. Unspecified medical attention was sought. Additional information has been requested.
Itchy rash on upper arm surrounding injection site. It came on March 14 and lasted 2 days. Then no rash for 3 days. Then it came back again worse, more red and puffy and itchy, on March 19. That only lasted one day.
Injection site pain; tiredness; headache; muscle pain; chills; joint pain; nausea;